FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH
Liver International · 2024
DOI: 10.1111/liv.16085 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Liver International, 2024. Verfasst von Laura Martínez-Arenas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology, Hepatobiliopancreatic Surgery and Transplant Laboratory, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Cirrhosis, Elasticity Imaging Techniques, Recurrence. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Generalitat Valenciana, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas.
Abstract (Originalsprache)
Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) recurrence after liver transplantation (LT) seems unavoidable and gradual. We aimed to evaluate the diagnostic accuracy in the post‐LT setting of patients transplanted for metabolic dysfunction‐associated steatohepatitis (MASH) of recurrent hepatic steatosis and fibrosis identified with FibroScan, compared to biopsy findings.
Methods
This prospective cohort study included adults transplanted for MASH between 2010 and 2022 in three LT centres in Spain who underwent FibroScan and biopsy at least 1‐year after LT.
Results
In total, 44 patients transplanted for MASH after LT were included. The median time from LT to biopsy and FibroScan was 24.5 (interquartile range [IQR]:16–46) and 26.0 (IQR: 16.8–41.5) months, respectively. The median time between biopsy and FibroScan was 2.0 (IQR: 0–5) months. On FibroScan, significant steatosis was diagnosed in about half of the patients ( n = 21, 47.7%), yet advanced fibrosis in only two cases (4.6%). On biopsy, a quarter of biopsied patients ( n = 11, 25%) had a MASH diagnosis, two (4.6%) with significant fibrosis and one (2.3%) with cirrhosis. All patients with liver stiffness measurement (LSM) values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatology, Hepatobiliopancreatic Surgery and Transplant Laboratory, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
- Department of Biotechnology, Universitat Politècnica de València, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain.
- Hepatology and Liver Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
- Hepatology and Liver Transplantation Unit, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
- Liver Unit and Digestive Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
ORCID-Profile: Laura Martínez-Arenas, Carmen Vinaixa, Sara Lorente, Fernando Díaz-Fontenla, Patrice Marques, Eva Montalvá, Ângela Carvalho-Gomes, Marina Berenguer
Förderung
- Generalitat Valenciana
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Sociedad Española de Trasplante Hepático
Zitieren
APA
Martínez-Arenas, L., Vinaixa, C., Conde, I., Lorente, S., Díaz-Fontenla, F., Marques, P., Pérez-Rojas, J., Montalvá, E., Carvalho-Gomes, Â., & Berenguer, M. (2024). FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. Liver International. https://doi.org/10.1111/liv.16085
Vancouver
Martínez-Arenas L, Vinaixa C, Conde I, Lorente S, Díaz-Fontenla F, Marques P, et al. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. Liver International. 2024. doi:10.1111/liv.16085
BibTeX
@article{MartnezArenas2024,
author = {Martínez-Arenas, Laura and Vinaixa, Carmen and Conde, Isabel and Lorente, Sara and Díaz-Fontenla, Fernando and Marques, Patrice and Pérez-Rojas, Judith and Montalvá, Eva and Carvalho-Gomes, Ângela and Berenguer, Marina},
title = {FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16085}
}
EUVIMED